Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA for Prevention of Postpartum Hemorrhage
NCT03326596Phase 4Withdrawn
- Sponsor
- Naval Medical Center San Diego
- Start
- Apr 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in postpartum hemorrhage (PPH), sponsored by Naval Medical Center San Diego. Planned start Apr 2018; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03326596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326596.